Jia, R., Kutzner, L., Koren, A., Runggatscher, K., Májek, P., Müller, A. C., . . . Kralovics, R. (2021). High-throughput drug screening identifies the ATR-CHK1 pathway as a therapeutic vulnerability of CALR mutated hematopoietic cells. Blood Cancer J.
Style de citation ChicagoJia, Ruochen, et al. "High-throughput Drug Screening Identifies the ATR-CHK1 Pathway As a Therapeutic Vulnerability of CALR Mutated Hematopoietic Cells." Blood Cancer J 2021.
Style de citation MLAJia, Ruochen, et al. "High-throughput Drug Screening Identifies the ATR-CHK1 Pathway As a Therapeutic Vulnerability of CALR Mutated Hematopoietic Cells." Blood Cancer J 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.